Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer
about
Irinotecan, continuous 5-fluorouracil, and low dose of leucovorin (modified FOLFIRI) as first line of therapy in recurrent or metastatic colorectal cancer.The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients.
P2860
Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@ast
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@en
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@nl
type
label
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@ast
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@en
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@nl
prefLabel
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@ast
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@en
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@nl
P2093
P2860
P356
P1433
P1476
Irinotecan plus folinic acid/c ...... f metastatic colorectal cancer
@en
P2093
Andreas Teufel
Bernd Adami
Christiane Zanke
Herbert Hohl
Jürgen Siebler
M Schroeder
Markus Moehler
Michael Heike
Peter R Galle
P2860
P2888
P356
10.1186/1471-2407-4-38
P407
P577
2004-07-20T00:00:00Z
P5875
P6179
1025068433